MedTrace Logo

Vectors Post Market: A Study to Assess Pain Relief Using Spinal Cord Stimulation

NCT03345472 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 175

Last updated 2020-11-03

Study results available
· View outcomes & findings →

Summary

This is a prospective, single-arm, multi-center study evaluating the efficacy of spinal cord stimulation (SCS) therapy for pain relief using high dose (HD) stimulation parameters delivered to neural targets identified during current commercial trial stimulation procedures. The study will evaluate changes in back and leg pain from baseline to 3, 6, and 12 months.

Conditions

Interventions

DEVICE

Spinal Cord Stimulation System

Implanted neurostimulation system (neurostimulator and leads) with high dose stimulation parameters.

Sponsors & Collaborators

  • MedtronicNeuro

    lead INDUSTRY

Principal Investigators

  • Vectors Post Market Clinical Research Study Team · Medtronic Restorative Therapies, Pain Therapy

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-30
Primary Completion
2019-02-04
Completion
2019-10-21
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03345472 on ClinicalTrials.gov